Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged 60 and older, with approximately 75% effectiveness against RSV-associated ...

The nation's infant mortality rate dropped last year after two years of hovering at a late-pandemic plateau.Some experts ...

For a broader group of infants—0 to 7 months old—RSV-NET showed a 43 percent drop in hospitalizations in the 2024–2025 RSV season, and NVSN saw a 28 percent drop. Again, when Houston was excluded from ...

By Dennis Thompson HealthDay ReporterTUESDAY, May 6, 2025 (HealthDay News) -- Newborns can be effectively protected against ...

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings, ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

Saskatchewan is expanding its infant immunization program to protect all newborns from Respiratory Syncytial Virus (RSV) ...

Each year, approximately 177,000 adults aged 65 and older are hospitalized in the United States due to RSV, and an estimated ...

A recent study revealed that newborns can be easily protected against respiratory syncytial virus infection by using the ...